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Abstract: In the present study, we firstly compared rat intestinal α-glucosidase inhibitory 
activity by different ethanol-aqueous extractions from the dried fruits of Terminalia chebula 
Retz. The enzymatic assay showed that the 80% ethanol extract was more potent against 
maltase  activity  than  both  50%  and  100%  ethanol  extracts.  By  HPLC  analysis,  it  was 
determined that the 80% ethanol extract had a higher content of chebulagic acid than each 
of 50% or 100% ethanol extract. Next, we investigated how efficiently chebulagic acid 
could inhibit sugar digestion by determining the glucose level on the apical side of the Caco-2 
cell monolayer. The result showed that the maltose-hydrolysis activity was down-regulated 
by chebulagic acid, which proved to be a reversible inhibitor of maltase in Caco-2 cells.  
On the other hand, chebulagic acid showed a weak inhibition of sucrose-hydrolysis activity. 
Meanwhile, chebulagic acid did not have an obvious influence on intestinal glucose uptake 
and was not effective on glucose transporters. Further animal studies revealed that the oral 
administration  of  chebulagic  acid  (100  mg/kg  body  weight)  significantly  reduced 
postprandial blood glucose levels by 11.1% in maltose-loaded Sprague-Dawley (SD) rats 
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compared with the control group, whereas the oral administration of chebulagic acid did 
not show a suppressive effect on postprandial hyperglycemia in sucrose- or glucose-loaded 
SD-rats. The results presented here suggest that chebulagic acid from T. chebula can be 
used to control blood glucose and manage type 2 diabetes, although clinical trials are needed. 
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1. Introduction 
Diabetes mellitus (DM) is a common metabolic disorder characterized by hyperglycemia, which is 
the main cause of complications related with micro- and macro-vascular diseases. DM is one of the 
three leading causes of  death  worldwide and constitutes  a major health problem [1]. Postprandial 
hyperglycemia results  from  abnormal  insulin  secretion by β-cells  in  response to  a meal,  impaired 
hepatic  glucose  production,  and  defective  glucose  uptake  by  peripheral  insulin-sensitive  tissues, 
particularly  the  skeletal  muscles.  Therefore,  control  of  postprandial  plasma  levels  is  critical  in 
treatment  of  not  only  diabetic  patients  but  also  individuals  with  impaired  glucose  tolerance  [2]. 
Mammalian intestinal α-glucosidase (EC 3.2.1.20) is the key enzyme, which catalyzes the final step in 
the digestive process of carbohydrates. Hence, α-glucosidase inhibitors can reduce postprandial blood 
glucose  levels  and  absorption  of  starch  and  disaccharides  [3].  Plant-derived  non-nutrients  were 
recently found to play potent roles in modulating postprandial hyperglycemia. It has been reported that 
food and herbs are rich sources of α-glucosidase inhibitors [4–6].  
The fruits of Terminalia chebula Retz (Combretaceae), also known as Xi-Qin-Ge in China, are a 
popular folk medicine for the treatment of various diseases, including digestive problems, diabetes, 
colic  pain,  chronic  cough,  sore  throat  and  asthma.  This  plant  has  been  studied  for  its  biological 
activities, such as antioxidant [7,8], anticancer [9] and antibacterial activity [10]. Recently, T. chebula 
was reported to show an anti-diabetic effect [11–13]. A number of chemical compounds, including 
polyphenols [14], tannins [15] and triterpenoids [16], have been isolated from this plant species. 
In the screening assay of α-glucosidase inhibitory activity for medicinal plants in China, we found 
that the methanol extract from the fruits of T. chebula showed a potent maltase inhibitory activity and 
the active compounds, chebulanin, chebulagic acid and chebulinic acid, were identified from this plant 
species  [17].  As  a  continued  study,  the  inhibitory  mode  of  action  of  chebulagic  acid  on  the  rat 
intestinal maltase-glucoamylase complex was determined [18]. In the present study, our objective was 
to  evaluate  the  intestinal  α-glucosidase  inhibitory  effect  by  chebulagic  acid  from  the  fruits  of  
T. chebula in vitro and in vivo. Therefore, we compared rat intestinal α-glucosidase inhibitory activity 
of  different  ethanol-aqueous  extractions  and  detected  chebulagic  acid  in  these  extracts  by  HPLC 
analysis.  Meanwhile,  we  determined  α-glucosidase  inhibitory  activity  of  chebulagic  acid  with  the 
Caco-2 cell monolayer, together with evaluating the postprandial blood glucose lowering effect of 
chebulagic acid after sugar (maltose, sucrose or glucose) loading in Sprague-Dawley (SD) rats. Int. J. Mol. Sci. 2012, 13  6322 
 
 
2. Results and Discussion 
2.1. Isolation of Chebulagic Acid from T. chebula Fruits 
Extraction of phenolic compounds from T. chebula is generally carried out using various types of 
organic solvents such as 95% ethyl acetate, hot water, 70% methanol, and 95% ethanol [19]. Ethanolic 
extraction of plant bioactives has displayed a higher yield compared with the aqueous extract [20].  
In  the  present  study,  we  compared  rat  intestinal  α-glucosidase  inhibitory  activity  of  different  
ethanol-aqueous extractions. Figure 1 shows the maltose-hydrolysis inhibitory activity of 50–100% 
ethanol extracts of T. chebula fruits. Each of these ethanol extracts significantly inhibited the maltase 
activity, and the enzymatic inhibition was dose-dependent. In the same assay condition, the IC50 value 
of chebulagic acid was determined to be 37 μg/mL (data not shown). On the other hand, the IC50 
values of 50%, 80% and 100% ethanol extracts against maltase were determined to be 173.6 μg/mL,  
51.7 μg/mL and 85.7 μg/mL, respectively. Hence, this result revealed that the 80% ethanol extract was 
more potent regarding its effect on maltase activity than both 50% and 100% ethanol extracts.  
Figure 1. Maltose-hydrolysis inhibitory activity of rat intestinal α-glucosidase by 50–80% 
ethanol extracts from the fruits of Terminalia chebula Retz. 
 
In order to ensure chebulagic acid in each ethanol extract, HPLC was used for further analysis. The 
compound at retention time 40.8 min was identified to be chebulagic acid, which was not found in the 
standard compound (Figure 2). Peak areas (mAU  Time (s)) of chebulagic acid identified in 50%, 
80%  and  100%  ethanol  extracts  were  determined  to  be  2.55  ×   10
4,  6.23  ×   10
4  and  4.61  ×   10
4, 
respectively. The 80% ethanol extract contained ~2.44- and ~1.35-times higher amounts of chebulagic 
acid  than  the  50%  and  100%  ethanol  extracts.  Therefore,  chebulagic  acid  was  prepared  with  our 
previous reported method [17] except that the dried fruit powders of T. chebula were extracted with 
80% ethanol instead of 70% methanol, and the yield of chebulagic acid was about 7.3%. The chemical Int. J. Mol. Sci. 2012, 13  6323 
 
 
structure of chebulagic acid was identified with 
1H-NMR and MS and the data were compared with 
data in the literature [17]. 
Figure  2.  HPLC-DAD  chromatograms  of 50–100% ethanol extracts  from  the fruits  of 
Terminalia chebula Retz. (A), 50% ethanol extract; (B), 80% ethanol extract; (C), 100% 
ethanol extract.  
 
2.2. α-Glucosidase Inhibitory Activity in Caco-2 Cells 
At late confluency and in culture, the human colon carcinoma cell line Caco-2 expresses the same 
morphological  characteristics  and  most  of  the  functional  properties  of  terminally  differentiated  
small-intestinal enterocytes, including the expression of proteins involved in the terminal digestion and 
uptake of sugars [21]. Caco-2 cells have been widely used as a culture model of human intestinal cells 
in studies to determine the α-glucosidase inhibitory effect by polyphenols [22–24]. In order to get the 
detailed information of chebulagic acid on mammalian intestinal α-glucosidase inhibitory activity, we 
investigated how efficiently chebulagic acid could inhibit sugar digestion by determining the content 
of liberated glucose on the apical side of the Caco-2 cell monolayer. Int. J. Mol. Sci. 2012, 13  6324 
 
 
Firstly, the effect of chebulagic acid on Caco-2 cell viability was evaluated using an MTT assay.  
At growth doses of 0.05–0.5 mM/well of chebulagic acid, cell viabilities were in the ranges of 95–99% 
(data not shown). This result significantly indicated a non-cytotoxic property of chebulagic acid on 
Caco-2 cells. Then, Caco-2 cells were treated with the concentrations of 0.05–0.5 mM/well levels 
chebulagic acid at the apical sides and the liberated glucose was measured on the apical sides. After 2 h 
of  incubation,  α-glucosidse activity  for the maltose hydrolysis was down-regulated, showing  73% 
inhibition at 0.5 mM/well, 62% inhibition at 0.25 mM/well, 51% inhibition at 0.1 mM/well, and 40% 
inhibition at 0.05 mM/well at the apical sides (Figure 3), respectively. PGG (1,2,3,4,6-penta-O-β-D-glucose) 
was  used  as  the  positive  control,  which  showed  74%  inhibition  of  the  maltose  hydrolysis  of  
α-glucosidse activity in the Caco-2 monolayer at the concentration of 0.5 mM/well.  
Figure  3.  Results  of  the  maltose  hydrolysis  assay  with  the  Caco-2  monolayer  in  the 
presence of chebulagic acid (0.05–0.5 mM/well). PGG, 1,2,3,4,6-penta-O-galloyl-β-D-glucose 
(0.5 mM/well) as a positive control. 
 
On the other hand, chebulagic acid showed a weak inhibition against sucrose-hydrolysis activity of 
α-glucosidase with the Caco-2 monolayer. As shown in Figure 4, the inhibitory effect of chebulagic 
acid at the apical sides of the Caco-2 monolayer was determined, and the inhibitions were 20–24% at 
the concentrations of 0.05–0.5 mM/well levels. Baicalein (5,6,7-trihydroxyflavone), a potent sucrase 
inhibitor,  showed  58%  inhibition  of  the  sucrose-hydrolysis  activity  of  α-glucoside  in  the  Caco-2 
monolayer  at  the  concentration  of  0.05  mM/well.  Our  previous  study  reported  that  the  inhibitory 
influence  of  chebulagic  acid  on  the  maltase-glucoamylase  complex  was  more  potent  than  on  the 
sucrase-isomaltase complex [18]. In agreement with the rat enzyme assay, chebulagic acid affected the 
Caco-2  maltase  reaction  more  than  the  Caco-2  sucrase  reaction.  Therefore,  the  anti-diabetic  
effect of chebulagic acid might  be attributed to maltose-hydrolysis inhibitory activity of intestinal  
α-glucosidase, which can retard the digestion of carbohydrates resulting in mitigating postprandial 
hyperglycemic excursions. Int. J. Mol. Sci. 2012, 13  6325 
 
 
Figure  4.  Results  of  the  sucrose  hydrolysis  assay  with  the  Caco-2  monolayer  in  the 
presence  of  chebulagic  acid  (0.05–0.5  mM/well).  Baicalein,  5,6,7-trihydroxyflavone  
(0.05 mM/well) as a positive control. 
 
In  our  previous  study,  analysis  of  a  Lineweaver-Burk  plot  of  rat  intestinal  maltase  kinetics 
suggested that chebulagic acid shows a non-competitive inhibition, in which chebulagic acid and the 
maltose substrate seem to bind simultaneously to the enzyme [17]. In order to determine whether 
chebulagic acid  is a  reversible maltase inhibitor, Caco-2 cells  were pretreated by  chebulagic  acid 
(0.05–0.5 mM/well levels) for 20 min at 37 ° C in 5% CO2 atmosphere. Then it was examined whether 
the  maltose-hydrolysis  activity  would  be  influenced  or  not  in  the  Caco-2  monolayer.  Compared  
with  the  control,  the  maltose-hydrolysis  activities  were  in  the  ranges  of  95–98%  at  the  dose  of  
0.05–0.5 mM/well levels pretreatment with chebulagic acid (Figure 5). It is obvious that chebulagic 
acid is a reversible inhibitor of maltase.  
Figure 5. Maltose-hydrolysis activity in the Caco-2 monolayer pretreated with chebulagic 
acid (0.05–0.5 mM/well) for 20 min at 37 ° C in 5% CO2 atmosphere.  
 
The liberated glucose from carbohydrate digestion is absorbed across the intestinal enterocytes via 
specific  transporters,  so  glucose  absorption  is  a  potent  target  for  better  glycemia  control  after  
high-carbohydrate  meals.  Inhibition  of  glucose  transporters  would  reduce  the  absorption  into  the  
small  intestine  and  consequently  suppress  postprandial  hyperglycemia  [24].  A  previous  study  Int. J. Mol. Sci. 2012, 13  6326 
 
 
reported  that  dietary  polyphenols,  such  as  (−)-epigallochatechingallate,  (−)-epichatechingallate  and 
(−)-epigallochatechin, are effective against glucose transporters and decrease glucose uptake by human 
intestinal Caco-2 cells [25]. In the present study, the effect of chebulagic acid on intestinal glucose 
uptake  was  investigated  by  using  Caco-2  monolayers.  As  shown  in  Figure  6,  compared  with  the 
control (glucose accumulation at the basal sides of the Caco-2 monolayer as 100% uptake), the glucose 
uptake rates were in the ranges of 94–98% in the presence of chebulagic acid (0.05–0.5 mM/well). 
This result suggests that chebulagic acid does not have an obvious influence on intestinal glucose 
uptake and has no effect on glucose transporters. 
Figure  6.  Glucose uptake in the Caco-2 monolayer in the presence of chebulagic acid  
(0.05–0.5 mM/well). 
 
2.3. Effect of Chebulagic Acid on Blood Glucose Level in Sugar-Loaded SD-Rats 
Our previous study showed that the oral administration of  T. chebula fruit extract significantly 
reduced postprandial blood glucose levels in SD-rats after oral loads of maltose [26]. To clarify the 
active compound associated with the suppression of the rat blood glucose level, an anti-hyperglycemic 
effect of chebulagic acid in the extract was investigated.  
Figure 7 shows the anti-hyperglycemic effects of chebulagic acid in maltose (A)-, sucrose (B)-, and 
glucose (C)-loaded SD-rats. In the maltose-loading test, the blood glucose level in the chebulagic acid 
group was significantly lower than that in the control group (Figure 7A). The blood glucose level  
30 min after administration was 126.7 ±  5.6 mg/dL in chebulagic acid (100 mg/kg, body weight) group, 
while in the control group the value was 165.2 ±  8.4 mg/dL. The raise in blood glucose level was 
reduced by 23.3% 30 min after gavage. The blood levels of chebulagic acid administrated SD-rats at 
60 and 120 min were 120.2 ±  7.2 and 72.1 ±  6.9 mg/dL, respectively, while the values in the controls 
were 126.4 ±  4.8 and 77.0 ±  9.1 mg/dL, respectively. The area under the glycemic curve (AUC0–120 min) 
for  chebulagic  acid  administrated  SD-rats  (207.8  ±   7.9  mg· h/dL  of  blood)  showed  a  significant 
reduction of 11.1% compared with that of the control group (233.64 ±  6.6 mg· h/dL of blood). The 
acute intake of acarbose reduced the incremental AUC0–120 min (199.6 ±  7.5 mg· h/dL of blood) in the 
SD-rats after maltose administration by 14.6%. Our animal study showed that the oral administration 
of chebulagic acid had a suppressive effect on hyperglycemia, which was similar to that seen with the 
administration of 3 mg/kg acarbose. Int. J. Mol. Sci. 2012, 13  6327 
 
 
On  the  other  hand,  in  the  sucrose-loading  test,  the  blood  glucose  level  in  the  chebulagic  acid  
(100  mg/kg,  body  weight)  group  was  not  significantly  different  from  that  of  the  control  group 
(Figure 7B). As in vitro Caco-2 sucrase inhibitory activity of chebulagic acid was weak (Figure 4), 
there seemed to be no blood glucose level reduction in the sucrose-loaded SD-rats by chebulagic acid. 
The result was similar to the previous report in which methanol extracts of dried flowers of Ranawara 
(Cassia auriculata) with a potent maltase inhibition did not significantly reduce the postprandial blood 
glucose levels in sucrose-loaded rats, because Ranawara showed a weak sucrase inhibitory activity [27].  
A glucose-loading test was also performed at a dose of 100 mg/kg. As shown in Figure 7C, the 
administration of chebulagic acid did not affect postprandial blood glucose levels in SD-rats after  
oral-loading  glucose.  According  to  the  result  obtained  in  glucose  uptake  by  the  Caco-2  monolayer 
(Figure 6), no blood glucose level reduction in glucose-loaded rats by chebulagic acid indicated that 
the  significant  hypoglycemic  effect  in  maltose-loaded  SD-rats  resulted  from  intestinal  maltase 
inhibition, not from intestinal glucose transporter inhibition.  
Figure 7. Anti-hyperglycemic effects of chebulagic acid on SD-rats. Fasted rats were given 
2 g/kg of maltose (A), 2 g/kg of sucrose (B) and 2 g/kg of glucose (C), with or without  
100 mg/kg of chebulagic acid (■) and vehicle (control: ♦). Acarbose (○) was used as a 
positive control for maltose-loaded SD-rats (A). Data are presented as  the mean ±  SD  
(n = 5). * p < 0.05 vs. control.  
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Figure 7. Cont. 
 
3. Materials and Methods  
3.1. Materials 
The dried fruits of T. chebula were purchased from a local herbal market in Chengdu, China, and 
properly  identified  at  the  Department  of  Pharmacology,  Hua  Xi  Medicinal  Center  of  Sichuan 
University. The voucher specimen (No. 2011070202) is deposited in the department of Public Health, 
Hua Xi Medical Center of Sichuan University. Maltose was purchased from Merck Chemical Supplies. 
All other chemicals were purchased from Sigma-Aldrich Company unless otherwise stated. All other 
chemicals used including the solvents were of an analytical grade. 
3.2. Preparation of Sample Extraction 
The  dried  fruits  of  T.  chebula  were  powdered  in  a  blender.  For  extraction,  every  gram  of  the 
powered fruits was suspended in 20 mL of an extraction solvent: One hundred percent ethanol, 80% 
ethanol (ethanol/water = 8:2, v/v) or 50% ethanol (ethanol/water = 1:1, v/v). Extractions were carried 
out at room temperature for 36 h with continuous stirring and then treated with ultrasonication for 1 h. 
After filtration, the solvent from this extract was evaporated and the residues were lyophilized. The 
lyophilized powders were stored at −20 °C before use.  
3.3. Determination of Chebulagic Acid in Each Extract  
An  amount  of  10  mg  of  each  of  the  above-mentioned  extracts  was  dissolved  in  1  mL  of  
70% methanol (a final concentration of 10 mg/mL), which was then passed through a HP020 filter 
(Advantec). Then 20 μL of this filtrate was injected directly for reverse-phase-HPLC analysis. The 
HPLC system (Agilent 1200 Series Purification System) consisted of an injector (G1328B), a column 
oven  (25  ° C),  a  pump  (G1311A),  a  diode  array  detector  (G1315D),  and  a  reverse-phase  column 
(Inertsil PREP-ODS-3, 4.6 ×  250 mm, 5 μm, GL-Science). A linear gradient elution system, using 
solvent A and B (A = methanol; B = 0.1% formic acid in ultrapure water) according to the following 
profile: 0–10 min, 10–20% A, 90–80% B; 10–30 min, 20–30% A, 80–70% B; 30–50 min, 30–40% A, Int. J. Mol. Sci. 2012, 13  6329 
 
 
70–60% B; 50–70 min, 40–50% A, 60–50% B; 70–90 min, 50–100% A, 50–0% B). The flow rate was 
maintained constant at 1.2 mL/min, and the phenolic compounds were monitored at 280 nm.  
3.4. Isolation of Chebulagic Acid 
Chebulagic acid was prepared with our previous reported method [17] except that the dried fruit 
powders of  T.  chebula  were extracted with  80% ethanol instead of 70% methanol.  The  chemical 
structure of chebulagic acid was identified with 
1H-NMR and MS and the data were compared with 
data in the literature [17].  
3.5. Intestinal α-Glucosidase Inhibitory Activity  
The α-glucosidase inhibitory activity was measured as described previously [17]. The crude enzyme 
solution prepared from rat intestinal acetone powder (Sigma-Aldrich) was used as the small intestinal 
α-glucosidase.  The  reaction  mixture  consisted  of  a  crude  enzyme  solution  (0.05  mL),  a  substrate 
(maltose, 3.5 mM, 0.35 mL) in 0.1 M potassium phosphate buffer (pH 6.3), and the test sample in  
50% DMSO (0.1 mL). After incubation for 15 min at 37 ° C, the reaction was stopped by adding  
0.75 mL of 2 M Tris-HCl buffer (pH 7.0). The reaction mixture was passed through a short column of 
basic alumina, and the amount of liberated glucose was measured by the glucose oxidase method. The 
concentration of inhibitors required for inhibiting 50% of the α-glucosidase activity under the assay 
conditions was defined as the IC50 value.  
3.6. Assay for the Caco-2 Cells Experiment 
The  intestinal  epithelial  cell  line,  Caco-2,  derived  from  a  human  colon  adenocarcinoma  was  
used as an intestinal membrane model. Caco-2 cells used in this study were obtained from the National 
Chengdu  Center  for  Safety  Evaluation  of  Drugs.  Cell  viability  was  estimated  by  the  MTT  
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium  bromide)  assay.  Briefly,  Caco-2  cells  were 
seeded in a 96 well plate at 1 ×  10
5 cells/mL. Twenty-four hours after plating, cells were treated with 
various
 concentrations of test sample and were incubated for an additional 2 h at 37 ° C. After the cell 
culture medium was removed, the cells were incubated with 20 μL of MTT solutions (5 mg/mL) in 100 μL 
of  medium  at  37  ° C  for  4  h.  The  insoluble  derivative  formed  by  cellular  dehydrogenase  was 
solubilized with DMSO and absorbance was measured at 490 nm with a microplate reader. 
Alpha-Glucosidase inhibitory activity in Caco-2 cell lines was performed with the previous method [28]. 
Briefly, Caco-2 cells were fed on polyethylene terephthalate membranes (Falcon, pore size: 0.4 μm, 
pore density 1.6 ×  10
6 pores/cm
2, diameter: 23.1 mm) in a 6 well plate. After 16 days, the cell culture 
medium was removed and both the apical and basal chambers were washed 3 times with 2 mL of 
phosphate-buffered  saline  (PBS).  The  culture  medium  in  the  apical  chamber  was  replaced  with  a 
reaction mixture containing chebulagic acid (0.05 mL) and a sugar solution (28 mM maltose or 28 mM 
sucrose) in PBS (0.95 mL) as a substrate. In the basal chamber 1 mL of PBS was added instead of the 
culture medium. After the Caco-2 enzyme reaction at 37 ° C in 5% CO2 atmosphere for 2 h, 500 μL of 
each bathing solution  on  the apical  side  was  transferred to pass  through a short  column of basic 
alumina, and the content of liberated glucose was determined by the glucose oxidase method.  Int. J. Mol. Sci. 2012, 13  6330 
 
 
The effect of chebulagic acid on α-glucosidase inhibitory activity was observed in Caco-2 cell lines. 
Briefly, Caco-2 cells (1.6 ×  10
6/mL) were fed onto a 12 well plate. After 16 days, the cell culture 
medium was removed and cells were treated with chebulagic acid in 1 mL of PBS. After 20 min 
incubation at 37 ° C in 5% CO2 atmosphere, the treatment solution in each well was removed and the 
cells were washed twice with PBS. Then,  the maltose-hydrolysis activity in  the Caco-2 cells  was 
determined as described. 
The effect of chebulagic acid on glucose uptake was tested with Caco-2 cells lines in a 6 well plate. 
After 16 days, the cell culture medium was removed and both the apical and basal chambers were 
washed 3 times with 2 mL of phosphate-buffered saline (PBS). The culture medium in the apical 
chamber was  replaced  with a reaction mixture containing chebulagic  acid  (0.05 mL) and 28  mM 
glucose in PBS (0.95 mL). In the basal chamber 1 mL of PBS was added instead of the culture medium. 
After incubation at 37 ° C in 5% CO2 atmosphere for 2 h, the glucose levels on the basal side were 
determined as described. 
3.7. Animal Experimental  
Six-week-old male Sprague-Dawley (SD) rats were purchased from the Laboratory Animal Center, 
Sichuan Academy of Medical Sciences. SD-rats were housed in an air-conditioned environment and 
with a 12 h light/dark cycle. The temperature was maintained at 22 ±  1 ° C and the relative humidity 
was  55  ±   10%.  The  animals  were  provided  with  standard  laboratory  animal  feed  and  water  
ad  libitum.  The  SD-rats  were  fasted  for  12  h  and  divided  into  groups  according  to  body  weight  
(200–250 g, n = 5). Each sample was dissolved in water and administrated by gavage. In the control 
group, 1 mL of 2 g/kg of a sugar (maltose, sucrose or glucose) solution was administrated to each rat. 
In  the  sample-treated  group,  SD-rats  were  given  chebulagic  acid  (100  mg/kg  body  weight)  or  a 
positive  control,  acarbose  (3  mg/kg  body  weight).  Ten  minutes  after  oral  administration,  the  
sugar-loading test was done. Blood samples were collected from the tips of the rats’ tails at 30, 60, 90 
and 120 min after each sugar loading. The blood glucose levels were measured immediately with a 
commercial glucometer and test-strips (GT-1640, Kyoto, Japan). 
All experiments were carried out in accordance with the ethical guidelines of the Sichuan Province 
Experimental Animal Management Committee and were in complete compliance with the National 
Institutes of Health Guide for the Care and Use of Laboratory Animals. 
3.8. Statistical Analysis 
Data were reported as mean ±  standard deviation of mean. Statistical analyses were performed with 
Student’s t-test using the SPSS program (version 12.0 for Windows, SPSS Inc., Chicago, IL, USA). 
Values were considered to differ significantly if the p value was less than 0.05. 
4. Conclusions  
Mammalian intestinal α-glucosidase inhibitors can reduce postprandial plasma glucose levels and 
absorption of starch and disaccharides, and play potent roles in modulating postprandial hyperglycemia. 
In a previous study, we reported that the methanol extract from the fruits of T. chebula showed a Int. J. Mol. Sci. 2012, 13  6331 
 
 
potent  maltase  inhibitory  activity  and  the  active  compounds,  chebulanin,  chebulagic  acid  and 
chebulinic  acid,  were  identified  from  this  plant.  In  the  present  study,  we  compared  rat  intestinal  
α-glucosidase inhibitory activities  of  different  ethanol-aqueous  extractions  from  the dried fruits of  
T. chebula. The enzymatic assay showed that the 80% ethanol extract had a more potent effect on 
maltase  activity  than  both  50%  and  80%  ethanol  extracts.  HPLC  analysis  revealed  that  the  80% 
ethanol extract contained a higher content of chebulagic acid than either the 50% or 100% ethanol 
extract. In a Caco-2 cell model, α-glucosidase activity for maltose hydrolysis was down-regulated by 
chebulagic acid, which is a reversible inhibitor of maltase. On the other hand, chebulagic acid showed 
a weak inhibition of sucrose-hydrolysis activity and did not affect intestinal glucose uptake by Caco-2 
cells.  Furthermore,  chebulagic  acid  significantly  reduced  postprandial  blood  glucose  level  in  
maltose-loaded SD-rats. So, it was suggested that chebulagic acid from T. chebula may be useful for 
suppressing  postprandial  hyperglycemia  as  a  potent  anti-diabetic  agent,  although  clinical  trials  
are needed. 
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